Infants born preterm are especially vulnerable to cerebral palsy, the risk of which is inversely proportional to gestational age at birth. The contribution of prematurity to the overall burden of cerebral palsy is substantial. This article reviews and discusses potential antenatal and postnatal neuroprotective approaches targeted at the numerous risk factors associated with cerebral palsy among preterm infants, including magnesium sulfate.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados